Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Cady Noda"'
Publikováno v:
J Pediatr Pharmacol Ther
OBJECTIVE This study aimed to evaluate the use of levofloxacin for the prevention of bacterial infections in pediatric patients with acute myeloid leukemia or those undergoing hematopoietic stem cell transplantation. METHODS This study was a single-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46acfbf2018c78a58fe5ba22a1787c13
https://doi.org/10.5863/1551-6776-25.7.629
https://doi.org/10.5863/1551-6776-25.7.629
Autor:
Cady Noda, India Sisler
Publikováno v:
J Pediatr Pharmacol Ther
Complement activation has been implicated in delayed hemolytic transfusion reaction (DHTR) in patients with sickle cell disease (SCD), and eculizumab has been reported as an effective treatment for patients with DHTR. Previously reported patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d49c1f06fdd3b8138433f06b85a034f
https://europepmc.org/articles/PMC9400185/
https://europepmc.org/articles/PMC9400185/
Publikováno v:
The American surgeon.
Background Since the 1990s, the U.S. has faced increasing rates of opioid overuse, misuse, and overdose deaths. To combat the opioid epidemic, there have been national initiatives to limit prescribing of opioids. At our institution, we implemented an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f87d8b4d5caa195fe2a07382e409fdf
https://pubmed.ncbi.nlm.nih.gov/34794319
https://pubmed.ncbi.nlm.nih.gov/34794319
Autor:
Cady Noda, India Sisler
Compliment activation has been implicated in Delayed Hemolytic Transfusion Reaction (DHTR) in patients with sickle cell disease, and eculizumab has been reported as an effective treatment for patients with DHTR. Previously reported patients with SCD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64cf28521e7dcde1761d6617a8ec0788
https://doi.org/10.22541/au.160322422.22876901/v1
https://doi.org/10.22541/au.160322422.22876901/v1
Effect of Plasmapheresis on the Anti-Factor Xa Activity of Enoxaparin in an Obese Adolescent Patient
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 37:e16-e20
To our knowledge, the effect of plasmapheresis on the anti-factor Xa activity of enoxaparin has never been reported. We describe a 13-year-old, obese (92-kg) girl who was treated with enoxaparin for a pulmonary embolism while receiving plasmapheresis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67eb52fb9b6c6d7b0212fed2e2a2f1b3
https://doi.org/10.1002/phar.1907
https://doi.org/10.1002/phar.1907
The pharmacokinetics of tobramycin in patients with ciliary dyskinesia have not been previously reported. A 10-year-old female patient with primary ciliary dyskinesia was admitted to the general pediatrics floor with an acute respiratory exacerbation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8451ba3857419bfe0e9d3961510ef3f3
https://europepmc.org/articles/PMC5916445/
https://europepmc.org/articles/PMC5916445/
Publikováno v:
Pediatric bloodcancer. 65(10)
BACKGROUND Vaso-occlusive crisis (VOC) is frequent in children with sickle cell disease (SCD) creating significant burden on patients, families, and emergency departments (ED). The objective of the project was to reduce the admission rate for childre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d502838afa7fc0fab6c79cc5ec7ac3a
https://pubmed.ncbi.nlm.nih.gov/29856534
https://pubmed.ncbi.nlm.nih.gov/29856534
Autor:
Noda, Cady1 cady.noda@vcuhealth.org, Sisler, India2
Publikováno v:
Journal of Pediatric Pharmacology & Therapeutics. 2022, Vol. 27 Issue 6, p569-572. 4p.
Publikováno v:
Journal of Pediatric Pharmacology & Therapeutics. 2020, Vol. 25 Issue 7, p629-635. 7p.
Publikováno v:
Pediatric Blood & Cancer; Oct2018, Vol. 65 Issue 10, p1-1, 8p